In 1985 was created Pharmaceutical Product Development, which is appeared as Corporate Investor. The company was established in North America in United States. The main department of described Corporate Investor is located in the Wilmington.
The typical case for the fund is to invest in rounds with 1 participant.
The top activity for fund was in 2009. Deals in the range of more than 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
We can highlight the next thriving fund investment areas, such as Advice, Therapeutics. Among the various public portfolio startups of the fund, we may underline Auven Therapeutics Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
This organization was formed by Fred Eshelman.
| Fund Name | Location |
| AUG Management | - |
| Barunson E&A | Seoul-t'ukpyolsi, South Korea, Yongsan |
| BWG Ventures, LLC (Florida) | Florida, Miami, United States |
| CornerstoneCapital | Frankfurt, Germany, Hessen |
| Credit Mutuel Arkea | Bretagne, France, Le Relecq-kerhuon |
| Duopharma Biotech | Malaysia, Selangor, Selangor |
| Innovation Norway | Norway, Oslo |
| Jinjiang Capital | Changzhou, China, Zhejiang |
| Lean Venture | Norway, Oslo |
| Pintu Media | Beijing, Beijing, China |
| Radar Partners | California, Palo Alto, United States |
| RCF Group | Ohio, United States, West Chester |
| REMUS Capital | Boston, Massachusetts, United States |
| Serena Ventures | California, San Francisco, United States |
| The Sparkle Fund | - |
| William Morris Agency | Beverly Hills, California, United States |
| Xinwen Ziben | Beijing, Beijing, China |
| Yucatan Rock Ventures | California, Saratoga, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Medable | $78M | 15 Apr 2021 | Palo Alto, California, United States | ||
Medable | $91M | 19 Nov 2020 | Palo Alto, California, United States | ||
Liquidia Technologies | 22 Apr 2010 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Medable | $78M | 15 Apr 2021 | Palo Alto, California, United States | ||
Medable | $91M | 19 Nov 2020 | Palo Alto, California, United States | ||
Liquidia Technologies | 22 Apr 2010 | North Carolina, United States |
